KR102199387B1 - Teriyaki Sauce having high biological active materials and preparation method thereof - Google Patents
Teriyaki Sauce having high biological active materials and preparation method thereof Download PDFInfo
- Publication number
- KR102199387B1 KR102199387B1 KR1020190039279A KR20190039279A KR102199387B1 KR 102199387 B1 KR102199387 B1 KR 102199387B1 KR 1020190039279 A KR1020190039279 A KR 1020190039279A KR 20190039279 A KR20190039279 A KR 20190039279A KR 102199387 B1 KR102199387 B1 KR 102199387B1
- Authority
- KR
- South Korea
- Prior art keywords
- sauce
- cheonggukjang
- prepared
- teriyaki
- powder
- Prior art date
Links
- 235000015067 sauces Nutrition 0.000 title claims abstract description 105
- 238000002360 preparation method Methods 0.000 title description 18
- 239000011149 active material Substances 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 45
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 37
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 37
- 235000008434 ginseng Nutrition 0.000 claims abstract description 37
- 239000011812 mixed powder Substances 0.000 claims abstract description 35
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims abstract description 34
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims abstract description 32
- 241000121220 Tricholoma matsutake Species 0.000 claims abstract description 31
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 20
- 244000068988 Glycine max Species 0.000 claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 claims abstract description 19
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000021329 brown rice Nutrition 0.000 claims abstract description 17
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims abstract description 17
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims abstract description 16
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims abstract description 16
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims abstract description 16
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000005875 quercetin Nutrition 0.000 claims abstract description 16
- 229960001285 quercetin Drugs 0.000 claims abstract description 16
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims abstract description 15
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 15
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 15
- 229940074393 chlorogenic acid Drugs 0.000 claims abstract description 15
- 235000001368 chlorogenic acid Nutrition 0.000 claims abstract description 15
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims abstract description 15
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims abstract description 15
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims abstract description 15
- 229940010454 licorice Drugs 0.000 claims abstract description 15
- 240000004670 Glycyrrhiza echinata Species 0.000 claims abstract description 14
- 235000008216 herbs Nutrition 0.000 claims abstract description 12
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 7
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 7
- 240000002045 Guettarda speciosa Species 0.000 claims abstract description 4
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 3
- 241000208340 Araliaceae Species 0.000 claims abstract 6
- 239000000843 powder Substances 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000004922 lacquer Substances 0.000 claims description 26
- 238000000855 fermentation Methods 0.000 claims description 25
- 230000004151 fermentation Effects 0.000 claims description 24
- 239000007787 solid Substances 0.000 claims description 14
- 241001247821 Ziziphus Species 0.000 claims description 12
- 235000000346 sugar Nutrition 0.000 claims description 12
- 244000044283 Toxicodendron succedaneum Species 0.000 claims description 11
- 235000013311 vegetables Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 235000013555 soy sauce Nutrition 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 6
- 239000000052 vinegar Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract description 10
- 230000003078 antioxidant effect Effects 0.000 abstract description 7
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 208000008589 Obesity Diseases 0.000 abstract description 3
- 235000020824 obesity Nutrition 0.000 abstract description 3
- 240000004371 Panax ginseng Species 0.000 description 31
- 239000000523 sample Substances 0.000 description 26
- 238000002835 absorbance Methods 0.000 description 20
- 230000002292 Radical scavenging effect Effects 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- RMTXUPIIESNLPW-UHFFFAOYSA-N 1,2-dihydroxy-3-(pentadeca-8,11-dienyl)benzene Natural products CCCC=CCC=CCCCCCCCC1=CC=CC(O)=C1O RMTXUPIIESNLPW-UHFFFAOYSA-N 0.000 description 13
- QARRXYBJLBIVAK-UEMSJJPVSA-N 3-[(8e,11e)-pentadeca-8,11-dienyl]benzene-1,2-diol;3-[(8e,11e)-pentadeca-8,11,14-trienyl]benzene-1,2-diol;3-[(8e,11e,13e)-pentadeca-8,11,13-trienyl]benzene-1,2-diol;3-[(e)-pentadec-8-enyl]benzene-1,2-diol;3-pentadecylbenzene-1,2-diol Chemical compound CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O.CCCCCC\C=C\CCCCCCCC1=CC=CC(O)=C1O.CCC\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.C\C=C\C=C\C\C=C\CCCCCCCC1=CC=CC(O)=C1O.OC1=CC=CC(CCCCCCC\C=C\C\C=C\CC=C)=C1O QARRXYBJLBIVAK-UEMSJJPVSA-N 0.000 description 13
- IYROWZYPEIMDDN-UHFFFAOYSA-N 3-n-pentadec-8,11,13-trienyl catechol Natural products CC=CC=CCC=CCCCCCCCC1=CC=CC(O)=C1O IYROWZYPEIMDDN-UHFFFAOYSA-N 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 13
- 238000000605 extraction Methods 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 13
- DQTMTQZSOJMZSF-UHFFFAOYSA-N urushiol Natural products CCCCCCCCCCCCCCCC1=CC=CC(O)=C1O DQTMTQZSOJMZSF-UHFFFAOYSA-N 0.000 description 13
- 244000061520 Angelica archangelica Species 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- 235000019629 palatability Nutrition 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 241000411851 herbal medicine Species 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 230000001766 physiological effect Effects 0.000 description 9
- 244000046052 Phaseolus vulgaris Species 0.000 description 8
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 8
- 235000011957 flavonols Nutrition 0.000 description 8
- 239000013642 negative control Substances 0.000 description 8
- 230000002000 scavenging effect Effects 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 150000007965 phenolic acids Chemical class 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000013566 allergen Substances 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 102000019280 Pancreatic lipases Human genes 0.000 description 5
- 108050006759 Pancreatic lipases Proteins 0.000 description 5
- 230000003579 anti-obesity Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 150000007946 flavonol Chemical class 0.000 description 5
- 229940116369 pancreatic lipase Drugs 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 108010028144 alpha-Glucosidases Proteins 0.000 description 4
- 230000003178 anti-diabetic effect Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000019624 protein content Nutrition 0.000 description 4
- 239000012064 sodium phosphate buffer Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 235000021186 dishes Nutrition 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- -1 lignase Proteins 0.000 description 3
- 235000019645 odor Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 241000512259 Ascophyllum nodosum Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 150000002216 flavonol derivatives Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 238000012812 general test Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000013095 identification testing Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000009048 phenolic acids Nutrition 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- WLDWSGZHNBANIO-UHFFFAOYSA-N 2',5'-Dihydroxyacetophenone Chemical compound CC(=O)C1=CC(O)=CC=C1O WLDWSGZHNBANIO-UHFFFAOYSA-N 0.000 description 1
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- CUKSFECWKQBVED-INIZCTEOSA-N Decursin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-INIZCTEOSA-N 0.000 description 1
- BGXFQDFSVDZUIW-UHFFFAOYSA-N Decursinol Natural products O1C(=O)C=CC2=C1C=C1OC(C)(C)C(O)CC1=C2 BGXFQDFSVDZUIW-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- CUKSFECWKQBVED-UHFFFAOYSA-N Grandivittin Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-UHFFFAOYSA-N 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 244000242291 Lemna paucicostata Species 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000159243 Toxicodendron radicans Species 0.000 description 1
- 241000121219 Tricholoma Species 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000002792 antioxidant assay Methods 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- JXZWWIMXTVJNSF-UHFFFAOYSA-N decursin Natural products CC(=CC(=O)OC1Oc2cc3OC(=O)C=Cc3cc2CC1(C)C)C JXZWWIMXTVJNSF-UHFFFAOYSA-N 0.000 description 1
- BGXFQDFSVDZUIW-LBPRGKRZSA-N decursinol Chemical compound O1C(=O)C=CC2=C1C=C1OC(C)(C)[C@@H](O)CC1=C2 BGXFQDFSVDZUIW-LBPRGKRZSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 235000013364 duck meat Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940040461 lipase Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- SIXLXDIJGIWWFU-UHFFFAOYSA-N pyritinol Chemical compound OCC1=C(O)C(C)=NC=C1CSSCC1=CN=C(C)C(O)=C1CO SIXLXDIJGIWWFU-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000019600 saltiness Nutrition 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000009645 skeletal growth Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001476 sodium potassium tartrate Substances 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- QGVNJRROSLYGKF-UHFFFAOYSA-N thiobarbital Chemical compound CCC1(CC)C(=O)NC(=S)NC1=O QGVNJRROSLYGKF-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-N trans-cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A23L11/20—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/70—Germinated pulse products, e.g. from soy bean sprouts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/50—Soya sauce
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/16—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by heating loose unpacked materials
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
- A23L31/10—Yeasts or derivatives thereof
- A23L31/15—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2116—Flavonoids, isoflavones
- A23V2250/21168—Quercetin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
Abstract
본 발명에서는 옻나무, 현미 및 콩으로 구성되는 혼합분말의 송이버섯균사체 발효 추출물; 산양삼과 인삼의 혼합삼, 당귀, 백수오, 천궁, 감초와 대추로 구성되는 한방약재의 추출물; 및 청국장 소스 스톡을 포함하여, 퀘르세틴, 에피갈로카테킨 및 클로로제닉산의 생리활성성분을 고함량으로 함유하는 데리야끼 소스 및 그 제조방법이 개시된다.
본 발명에 따른 데리야끼 소스는 항산화 활성, 당뇨병 개선 및 비만 개선의 기능성도 향상되어 있다. In the present invention, matsutake mushroom mycelium fermented extract of mixed powder consisting of sumac, brown rice and soybeans; Extracts of herbal medicinal herbs consisting of mixed ginseng of wild ginseng and ginseng, angelica, baeksuoh, cheonggung, licorice and jujube; And teriyaki sauce containing a high content of physiologically active components of quercetin, epigallocatechin, and chlorogenic acid, including cheonggukjang sauce stock, and a method for producing the same are disclosed.
Teriyaki sauce according to the present invention has improved antioxidant activity, improved diabetes and improved obesity.
Description
본 발명은 생리활성성분이 증진된 데리야끼 소스 및 그 제조방법에 관한 것으로, 더 상세하게는 옻나무, 현미 및 콩으로 구성되는 혼합분말의 송이버섯균사체 발효 추출물; 산양삼과 인삼의 혼합삼, 당귀, 백수오, 천궁, 감초와 대추로 구성되는 한방약재의 추출물; 및 청국장 소스 스톡을 포함하여, 퀘르세틴, 에피갈로카테킨 및 클로로제닉산의 생리활성성분을 고함량으로 함유하는 데리야끼 소스 및 그 제조방법을 제공하는 것이다.The present invention relates to a teriyaki sauce with improved physiologically active ingredients and a method for producing the same, and more particularly, to a fermented extract of matsutake mushroom mycelium of mixed powder consisting of sumac, brown rice and soybeans; Extracts of herbal medicinal herbs consisting of mixed ginseng of wild ginseng and ginseng, angelica, baeksuoh, cheonggung, licorice and jujube; And it is to provide a teriyaki sauce containing a high content of physiologically active components of quercetin, epigallocatechin, and chlorogenic acid, including cheonggukjang sauce stock, and a method for producing the same.
글로벌화로 다양한 서양의 음식을 접하기가 용이해지면서 서양식 요리법 특히, 소스류에 대한 관심도 증가하고 있다. 또한 한식의 세계화는 우리 전통식품이나 요리를 서양인의 입맛에 맞도록 새로이 개발하거나 개량하고자 하는 움직임도 가속화하고 있다.As globalization makes it easier to access various Western foods, interest in Western-style recipes, especially sauces, is also increasing. In addition, the globalization of Korean food is accelerating the movement to develop or improve Korean traditional foods and dishes to suit Western tastes.
데리야끼는 어패류에 간장양념을 덧발라 굽는 일본 요리이름으로 이 일본식 간장양념이 데리야끼 소스로 불리고 있다. 데리야끼 소스(sauce)는 간장을 베이스로 하는 소스로 걸쭉한 농도와 단맛, 짠맛을 지니고 있으며, 특유의 짜고 단맛으로 어패류 외에도 육류 요리에도 널리 적용되고 있다. 간장, 술, 다시마, 설탕 등을 넣고 졸여 만든다. Teriyaki is the name of a Japanese dish in which seafood is coated with soy sauce and grilled. This Japanese-style soy sauce is called teriyaki sauce. Teriyaki sauce (sauce) is a soy sauce-based sauce that has a thick consistency, sweetness, and saltiness, and is widely applied to meat dishes as well as fish and shellfish due to its characteristic salty and sweet taste. Boil it with soy sauce, liquor, kelp, and sugar.
데리야끼 소스에 기호성을 향상시키거나 기능성을 부가하기 위한 기술들이 개발되고 있다. 일례로서 숯불향이 가미되어 기호성이 증진된 데리야끼 소스 (등록번호 10-1919694호), 마디풀 추출액의 에틸 아세테이트층 분획물을 유효성분으로 함유함으로써 지방분해효소 억제 특성을 갖는 데리야끼 소스 (공개번호 10-2015-0064724호) 등이 알려져 있으나, 여전히 새로운 소재를 이용한 기호성 또는 기능성이 우수한 데리야끼 소스의 개발이 요구되고 있다.Technologies for improving palatability or adding functionality to teriyaki sauce are being developed. For example, teriyaki sauce (Registration No. 10-1919694) with improved palatability by adding charcoal fire, teriyaki sauce having lipolytic enzyme inhibitory properties by containing the ethyl acetate layer fraction of Madi grass extract as an active ingredient (Publication No. 10-2015- 0064724) and the like are known, but development of teriyaki sauce excellent in palatability or functionality using new materials is still required.
옻나무(Toxicodendron vernicifluum)는 위장의 소화, 간의 어혈 및 심장의 정혈 기능을 도와주며, 당뇨병, 부인병, 구충, 복통 및 빈혈의 치료에 효과가 있다고 하여 약재로서 많이 사용되었다. 그런데 옻나무는 수포, 가려움, 발진 등의 알레르기 또는 접촉성 피부염을 유발하는 우루시올(urushiol)을 함유하고 있어서 그 이용이 제한되었다. 그러나 옻나무는 우루시올 이외에 다양한 생리활성물질을 함유하고 있어 다양한 약리작용을 나타내어, 녹차, 잎새버섯 균사체, 또는 저온추출법을 이용하여 우루시올을 제거하려는 시도가 되어 왔으나 (등록특허 10-166139호, 10-1182743호, 10-1892617호), 여전히 새로운 제거기술이 요구되고 있다. Sumac ( Toxicodendron vernicifluum ) has been widely used as a medicinal agent because it helps digestion of the stomach, blood stagnation of the liver, and bleeding function of the heart. However, the use of lacquer is limited because it contains urushiol, which causes allergies or contact dermatitis such as blisters, itchiness, and rash. However, since lacquer tree contains various physiologically active substances other than urushiol, it exhibits various pharmacological actions, and attempts have been made to remove urushiol using green tea, mycelia of leaf mushrooms, or low-temperature extraction (Registration Patent No. 10-166139, 10-1182743 No., No. 10-1892617), a new removal technique is still required.
플라보놀의 일종인 퀘르세틴(quercetin)은 항산화, 항염증, 항균, 항바이러스, 암세포 증식억제, 혈압강하 및 모세혈관 강화 작용 등 다양한 약리 작용이 있다고 알려져 있다. 또한 에피갈로카테킨(epigallocatechin)은 리파아제 저해활성, 심혈관질환 등의 효과가 있는 것으로 알려져 있다. Quercetin, a type of flavonol, is known to have various pharmacological effects such as antioxidant, anti-inflammatory, antibacterial, antiviral, cancer cell proliferation inhibition, blood pressure lowering and capillary strengthening. In addition, epigallocatechin (epigallocatechin) is known to have effects such as lipase inhibitory activity and cardiovascular disease.
페놀산의 일종인 클로로제닉산(chlorogenic acid)은 항균 및 항염 등의 황성이 알려져 있다. Chlorogenic acid, a type of phenolic acid, is known for its antibacterial and anti-inflammatory properties.
따라서 상기 플라보놀과 페놀산 성분들이 고함량으로 함유된 데리야끼 소스의 개발이 요망되고 있는 실정이다. Therefore, the development of teriyaki sauce containing the flavonol and phenolic acid components in a high content is desired.
이에 본 발명자들은 종래 기술에서의 요구에 부응하기 위해 연구한 결과, 옻나무, 현미 및 콩으로 구성되는 혼합분말의 송이버섯균사체 발효 추출물과 산양삼과 인삼의 혼합삼, 당귀, 백수오, 천궁, 감초와 대추로 구성되는 한방약재의 추출물을 청국장 소스 스톡과 함께 포함하는 데리야끼 소스가, 퀘르세틴, 에피갈로카테킨 및 클로로제닉산 등의 생리활성성분을 고함량으로 함유하고 우수한 기능성(증진된 생리활성)을 갖는다는 것을 확인하고 본 발명을 완성하게 되었다.Accordingly, the present inventors studied in order to meet the requirements of the prior art. As a result of the study, the fermented extract of matsutake mycelia of mixed powder consisting of lacquer, brown rice and soybeans, and mixed ginseng of wild ginseng and ginseng, angelica, baeksuoh, cheongoong, licorice and Teriyaki sauce containing extracts of herbal medicinal herbs composed of jujube together with cheonggukjang sauce stock contains high content of physiologically active ingredients such as quercetin, epigallocatechin and chlorogenic acid, and has excellent functionality (enhanced physiological activity). After confirming that it had, the present invention was completed.
따라서 본 발명의 목적은 옻나무, 현미 및 콩으로 구성되는 혼합분말의 송이버섯균사체(Tricholoma matsudake mycelium) 발효 추출물; 산양삼과 인삼의 혼합삼, 당귀, 백수오, 천궁, 감초와 대추로 구성되는 한방약재의 추출물; 및 청국장 소스 스톡을 포함하고, 퀘르세틴, 에피갈로카테킨 및 클로로제닉산의 생리활성성분이 강화되고 증진된 기능성(생리활성)을 갖는 데리야끼 소스 및 그 제조방법을 제공하는 것이다.Therefore, an object of the present invention is a mixed powder consisting of lacquer, brown rice and soybean matsudake mycelium ( Tricholoma matsudake mycelium) ferment extract; Extracts of herbal medicinal herbs consisting of mixed ginseng of wild ginseng and ginseng, angelica, baeksuoh, cheonggung, licorice and jujube; And cheonggukjang sauce stock, to provide a teriyaki sauce containing quercetin, epigallocatechin, and chlorogenic acid, and having an enhanced functionality (physiological activity) and a method for producing the same.
상기 목적을 달성하기 위하여, 본 발명은 옻나무, 현미 및 콩으로 구성되는 혼합분말의 송이버섯균사체 발효 추출물; 산양삼과 인삼의 혼합삼, 당귀, 백수오, 천궁, 감초와 대추로 구성되는 한방약재의 추출물; 및 청국장 소스 스톡을 포함하고, 퀘르세틴, 에피갈로카테킨 및 클로로제닉산의 생리활성성분이 강화되고 우수한 기능성을 갖는 데리야끼 소스를 제공한다. In order to achieve the above object, the present invention is a matsutake mushroom mycelium fermented extract of mixed powder consisting of sumac, brown rice and soybeans; Extracts of herbal medicinal herbs consisting of mixed ginseng of wild ginseng and ginseng, angelica, baeksuoh, cheonggung, licorice and jujube; And cheonggukjang sauce stock, and the physiologically active components of quercetin, epigallocatechin and chlorogenic acid are enhanced, and teriyaki sauce having excellent functionality is provided.
옻나무 혼합분말 Lacquer mixed powder 송이버섯균사체Pine mushroom mycelium 발효 추출물 Fermented extract
본 발명의 데리야끼 소스는 옻나무, 현미 및 콩으로 구성되는 혼합분말의 송이버섯균사체 발효 추출물을 포함한다. The teriyaki sauce of the present invention includes a fermented extract of matsutake mycelia of mixed powder consisting of sumac, brown rice and soybeans.
상기 혼합분말은 옻나무 분말 60∼80%(w/w), 현미 분말 10∼20%(w/w) 및 콩 분말 10~20%(w/w)로 구성되는 것이 바람직하다. The mixed powder is preferably composed of lacquer powder 60-80% (w/w), brown rice powder 10-20% (w/w), and soybean powder 10-20% (w/w).
옻 분말이 60% 미만 시 생리활성이 충분하지 않을 수 있으며, 80% 초과 시 현미 분말 혹은 콩 분말이 양이 적어 송이버섯균사체 발효가 지연되어 오염될 수 있다. 현미 분말과 콩 분말이 각각, 10% 미만 시 송이버섯균사체 발효에 필요한 당과 단백질 함량이 부족하여 발효가 지연되어 오염될 수 있고, 20% 초과 시 옻 분말 양이 충분하지 않아 생리활성이 충분하지 않을 수 있다.If the amount of lacquer powder is less than 60%, the physiological activity may not be sufficient. If the amount of lacquer powder is less than 60%, the amount of brown rice or soybean powder is small, which may delay the fermentation of pine mushroom mycelium and cause contamination. If the amount of brown rice powder and soybean powder, respectively, is less than 10%, fermentation may be delayed due to insufficient sugar and protein content required for fermentation of matsutake mycelium, and if it exceeds 20%, the amount of lacquer powder is insufficient and thus physiological activity is insufficient. May not.
옻나무는 절단 후 100~120℃에서 30~60분 처리하여 살균한 후, 50~60℃에서 2~3일간 건조시킨 후 분쇄기로 초핑하여 분말화하여 사용한다. After cutting, lacquer is sterilized by treating at 100~120℃ for 30~60 minutes, dried at 50~60℃ for 2~3 days, then chopped with a grinder and powdered.
본 발명에서 발효는 상기 혼합분말에 약 50~60% 수분되도록 물을 가하여 1~2시간 정도 팽윤시키고 100∼120℃에서 30~60시간 동안 살균한 후, 송이버섯균사체를 3~6 %(v/w)로 접종하여 반고체 발효시켜 제조한다.In the present invention, fermentation is performed by adding water to about 50-60% moisture to the mixed powder, swelling it for about 1 to 2 hours, sterilizing at 100 to 120°C for 30 to 60 hours, and then adding 3 to 6% (v /w) and semi-solid fermentation.
본 발명에서 송이버섯 균사체를 사용할 경우, 다른 버섯균사체보다 셀룰라제(cellulase), 리그나제(lignase), 글루코시다제(glucosidase), 에스테라제(esterase), 프로테아제(protease) 등의 효소활성이 우수하여 알레르기 유발물질인 우루시울 분해뿐만 아니라 저분자 생리활성물질 생산에 유리하며, 송이버섯 특유의 향이 발효물에 가미될 수 있다. When using pine mushroom mycelium in the present invention, enzyme activities such as cellulase, lignase, glucosidase, esterase, and protease are superior to other mushroom mycelium. As a result, it is advantageous not only to decompose urushiul, which is an allergen, but also to produce low-molecular physiologically active substances, and the unique scent of pine mushrooms can be added to the fermented product.
상기와 같이 제조된 본 발명에 따른 옻나무 혼합분말 발효물은 알레르기 유발물질인 우리시울이 제거되어 무독화되었고 (표 1, 도 1), 송이버섯균사체로 발효되어 생리활성물질이 풍부하고, 송이버섯 향이 가미되어 기호성이 우수하다.The fermented lacquer tree mixed powder according to the present invention prepared as described above was detoxified by removing the allergen, Woori Siul (Table 1, Fig. 1), and fermented into matsutake mycelium, rich in physiologically active substances, and matsutake mushroom Excellent palatability due to the added scent.
본 발명에서 추출은 에탄올 추출이 바람직하다. 에탄올 추출은 40~70% 에탄올을 20 부피배 첨가하여 30~40℃에서 3~5시간 동안 600 rpm 속도를 유지하여 추출할 수 있다. 바람직하게는 동일한 조건으로 2회 반복 추출한 후, 여과지로 여과한 후 감압농축기를 이용하여 가용성 고형분 함량이 5~10 브릭스(brix)가 되도록 조정하여 추출물을 제조한다. 가용성 고형분이 상기 범위 미만이면 옻나무 혼합분말 발효물 유래의 생리활성이 충분하지 않고, 상기 범위 초과이면 쓴맛 등으로 인해 소스의 기호성에 문제점이 있다.The extraction in the present invention is preferably ethanol extraction. Ethanol extraction can be extracted by adding 40 to 70% ethanol by 20 volume times and maintaining a 600 rpm speed at 30 to 40°C for 3 to 5 hours. Preferably, the extract is prepared by repeating extraction twice under the same conditions, filtering through filter paper, and adjusting the soluble solid content to 5 to 10 brix using a vacuum concentrator. If the soluble solid content is less than the above range, the physiological activity derived from the fermented lacquer tree mixed powder is not sufficient, and if it exceeds the above range, there is a problem in the palatability of the sauce due to bitter taste and the like.
추출은 옻나무 혼합분말 발효물 단독 또는 하기 한방약재 분말과 혼합하여 수행될 수 있다. Extraction may be performed by mixing the fermented lacquer tree powder alone or with the following herbal medicine powder.
본 발명의 데리야끼 소스에서 옻나무 혼합분말 발효추출물은 데리야끼 소스 총 중량을 100 부피%로 할 때 3~6 부피%로 첨가된다. 3 부피% 미만이면 생리활성을 충분히 기대할 수 없고 6 부피% 초과이면 쓴맛 등의 기호성에 문제가 발생할 수 있다.In the teriyaki sauce of the present invention, the fermented extract of lacquer mixed powder is added in an amount of 3 to 6% by volume when the total weight of the teriyaki sauce is 100% by volume. If it is less than 3% by volume, physiological activity cannot be sufficiently expected, and if it is more than 6% by volume, problems in palatability such as bitter taste may occur.
한방약재의 추출물Herbal medicine extract
본 발명의 데리야끼 소스는 산양삼과 인삼의 혼합삼, 당귀, 백수오, 천궁, 감초와 대추로 구성되는 한방약재의 추출물을 포함한다. The teriyaki sauce of the present invention includes an extract of herbal medicinal herbs consisting of mixed ginseng of wild ginseng and ginseng, angelica, baekshou, cheonggung, licorice and jujube.
혼합삼은 산양삼과 인삼을 1~2 : 9~8의 중량비로 혼합하여 사용한다. 산양삼이 포함된 혼합삼은 인삼에 부족한 진세노사이드를 보충할 수 있다.Mixed ginseng is used by mixing wild ginseng and ginseng in a weight ratio of 1 to 2: 9 to 8. Mixed ginseng containing wild ginseng can supplement ginsenosides lacking in ginseng.
당귀는 혈액을 보충시켜주는 보혈효과가 있는 것으로 알려져 있으며, 약리활성성분으로는 코우마린 유도체인 데커신, 데커시놀, 엄벨리페론, β-시토스테롤 등이 함유되어 있다. Angelica is known to have a blood-replenishing effect that replenishes blood, and its pharmacologically active ingredients include decursin, decursinol, umbelliferone, and β-sitosterol, which are coumarin derivatives.
백수오는 덩이뿌리가 한방에서 생약재로 이용되며 골감소를 포함한 골질환 예방효과, 골격성장 및 인슐린 유사 성장인자의 생성을 유도, 고지혈증 지질 대사개선에 효능이 있는 것으로 알려져 있으며, 주성분으로는 시난디온 A, 2,5-디히드록시아세토페논, 시난콘 A 등이 함유되어 있다.Baeksu-o is known to be effective in improving the lipid metabolism of hyperlipidemia, as the tuber root is used as a herbal medicine in oriental medicine, and has the effect of preventing bone diseases including bone loss, inducing skeletal growth and the production of insulin-like growth factors, and improving lipid metabolism in hyperlipidemia. It contains 2,5-dihydroxyacetophenone and sinancon A.
천궁은 당귀과의 한약재로서, 다양한 생리활성성분을 포함하여, 혈액순환 개선, 심혈관계에 작용하여 혈관을 확장시키고 혈류를 증가, 혈액 응고 작용, 중추성 근이완 작용, 항염증 작용 등이 있다. Chungoong is a medicinal herb of the Angelicaaceae family. It contains various physiologically active ingredients, and has improved blood circulation, expanded blood vessels and increased blood flow by acting on the cardiovascular system, blood coagulation, central muscle relaxation, and anti-inflammatory effects.
감초는 콩과의 한약재로서, 직접적인 효능은 위장 보호 및 독성 중화. 특히 다른 약재의 독을 중화하고 효능을 완화시켜 효능이 적절히 배합되도록 하는 작용을 한다. Licorice is a medicinal herb of legumes, and its direct effect is to protect the stomach and neutralize toxicity. In particular, it works to neutralize the poison of other medicinal materials and alleviate the efficacy so that the efficacy is properly formulated.
대추는 베툴린산 등의 다양한 생리활성성분을 포함하여 위장을 보호, 항염, 진정 작용을 한다. Jujube contains various physiologically active ingredients such as betulinic acid to protect the stomach, anti-inflammatory and soothing.
상기 한방약재들은 각각 분쇄기로 분쇄하여 분말로 사용한다. Each of the herbal medicines is pulverized with a grinder and used as a powder.
본 발명의 한방약재에는 혼합삼 15~25%(w/w), 당귀 15~25%(w/w), 백수오15~25%(w/w), 천궁 15~25%(w/w), 감초 15~25%(w/w) 및 대추 15~25%(w/w)로 포함되는 것이 바람직하다.The herbal medicinal material of the present invention includes mixed ginseng 15-25% (w/w), angelica 15-25% (w/w), baeksuo 15-25% (w/w), and cheonggung 15-25% (w/w) ), licorice 15-25% (w/w) and jujube 15-25% (w/w) are preferably included.
본 발명에서 한방약재의 추출은 상기 옻나무 혼합분말 발효물의 추출과 동일한 방식으로 수행할 수 있다. 한방약재를 추출한 후, 가용성 고형분 함량이 5~10 브릭스(brix)가 되도록 조정하여 추출물을 제조한다. 가용성 고형분이 상기 범위 미만이면 생리활성을 충분하게 기대하기 어렵고, 상기 범위 초과이면 쓴맛 등으로 인해 소스의 기호성에 문제점이 있다.In the present invention, the extraction of the herbal medicinal material may be performed in the same manner as the extraction of the fermented lacquer mixed powder. After extracting the herbal medicinal material, the extract is prepared by adjusting the soluble solid content to 5-10 brix. If the soluble solid content is less than the above range, it is difficult to sufficiently expect physiological activity, and if it exceeds the above range, there is a problem in palatability of the sauce due to bitter taste and the like.
마찬가지로 추출은 한방약재 단독 또는 옻나무 혼합분말 발효물과 혼합하여 수행될 수 있다. Likewise, extraction may be carried out by mixing oriental medicinal herbs alone or fermented lacquer mixed powder.
본 발명의 데리야끼 소스에서 한방약재 추출물은 데리야끼 소스 총 중량을 100 부피%로 할 때 3~6 부피%로 첨가된다. 첨가량이 3 부피% 미만이면 생리활성을 충분히 기대할 수 없고 6 부피% 초과이면 쓴맛 등의 기호성에 문제가 발생할 수 있다.Herbal medicine extract from the teriyaki sauce of the present invention is added in an amount of 3 to 6% by volume when the total weight of the teriyaki sauce is 100% by volume. If the amount is less than 3% by volume, physiological activity cannot be sufficiently expected, and if it is more than 6% by volume, problems in palatability such as bitter taste may occur.
청국장 소스 Cheonggukjang sauce 스톡stock
본 발명의 데리야끼 소스는 청국장 소스 스톡을 포함한다. The teriyaki sauce of the present invention includes a stock of cheonggukjang sauce.
본 발명에서 '소스 스톡(stock)'이란 소스의 제조의 밑바탕이 되는 원액을 의미한다. In the present invention, "sauce stock" means an undiluted solution that is the basis for the manufacture of sauce.
본 발명에서 청국장 소스 스톡으로는 바람직하게는 바실러스 아밀로리퀴페시언스 MGD02 균주로 발효된 청국장 소스 스톡을 사용한다. In the present invention, as the cheonggukjang sauce stock, preferably, cheonggukjang sauce stock fermented with Bacillus amyloliquefacience MGD02 strain is used.
본 발명자들은 청국장 소스 스톡의 제조에 가장 적합한 균주인 '바실러스 아밀로리퀴페시언스 MGD02를 분리·동정하고 한국농업유전자원센터 (KACC)에 2017년 1월 5일 기탁하였다(수탁번호: KACC92158P). 바실러스 아밀로리퀴페시언스 MGD02 균주로 발효된 청국장은 특유의 악취가 저감되어 기호성이 우수하고, 저장안정성도 우수하였다. The present inventors isolated and identified'Bacillus amyloliquefacience MGD02, which is the most suitable strain for the production of cheonggukjang sauce stock, and deposited with the Korea Agricultural Genetic Resource Center (KACC) on January 5, 2017 (accession number: KACC92158P). Cheonggukjang fermented with Bacillus amyloliquefascience MGD02 strain reduced its characteristic odor, resulting in excellent palatability and excellent storage stability.
청국장의 소스 스톡은 바실러스 아밀로리퀴페시언스 MGD02 균주로 발효된 청국장을 건조하여 건조 청국장을 제조한 후, 건조 청국장에 물을 2~5 부피배로 첨가하여 끓여서 추출하고 여과한 후 20 ~ 40 브릭스로 농축하여 제조한다.The source stock of Cheonggukjang is dried Cheonggukjang fermented with Bacillus amyloliquefacience MGD02 strain to prepare dried Cheonggukjang, then added 2 to 5 volume times of water to the dried Cheonggukjang, boiled, extracted, filtered, and then made 20 to 40 brix. It is prepared by concentration.
본 발명에 따른 청국장 소스 스톡은 청국장 특유의 악취가 저감되고 저장안정성도 우수하다.The cheonggukjang sauce stock according to the present invention has a reduced odor characteristic of cheonggukjang and has excellent storage stability.
본 발명의 데리야끼 소스에서 청국장 소스 스톡은 데리야끼 소스 총 중량을 100 부피%로 할 때 50~ 60부피%로 첨가된다. 첨가량이 50 부피% 미만이면 발효산물에 의한 소스의 풍미 등이 부족하며, 60 부피% 초과이면 청국장 이취가 발생할 수 있는 문제점이 있다.In the teriyaki sauce of the present invention, the cheonggukjang sauce stock is added in an amount of 50 to 60% by volume when the total weight of the teriyaki sauce is 100% by volume. If the amount is less than 50% by volume, the flavor of the sauce due to the fermentation product is insufficient, and if it is more than 60% by volume, there is a problem that off-flavor of cheonggukjang may occur.
상기와 같은 추출물들과 청국정 소스 스톡을 포함하는 본 발명에 따른 데리야끼 소스는 퀘르세틴, 에피갈로카테킨 및 클로로제닉산의 생리활성성분이 각각 1,450 ㎍/ml 이상, 2,480 ㎍/ml 이상, 및 450 ㎍/ml 이상으로 강화되었다 (표 4, 표 5). Teriyaki sauce according to the present invention including the above extracts and cheonggukjeong sauce stock contains physiologically active components of quercetin, epigallocatechin, and chlorogenic acid, respectively, of 1,450 µg/ml or more, 2,480 µg/ml or more, and 450 It was enhanced to more than μg/ml (Table 4, Table 5).
본 발명의 또 다른 목적에 따라서, 본 발명은 다음과 같은 단계들을 포함하고, 퀘르세틴, 에피갈로카테킨 및 클로로제닉산의 생리활성성분이 강화되고 항산화 활성, 항당뇨 및 항비만 등의 생리활성이 증진된 데리야끼 소스의 제조방법을 제공한다: According to another object of the present invention, the present invention includes the following steps, and the physiologically active components of quercetin, epigallocatechin and chlorogenic acid are enhanced, and physiological activities such as antioxidant activity, anti-diabetes and anti-obesity are enhanced. Provides a method of making an enhanced teriyaki sauce:
ⅰ) 옻나무, 현미 및 콩으로 구성되는 혼합분말을 송이버섯균사체로 발효하여 에탄올 추출하여 5~10 브릭스로 농축하는 단계; I) fermenting the mixed powder consisting of lacquer, brown rice, and soybeans with pine mushroom mycelium, extracting ethanol, and concentrating to 5-10 brix;
ⅱ) 산양삼과 인삼의 혼합삼, 당귀, 백수오, 천궁, 감초와 대추로 구성되는 한방약재를 에탄올 추출하여 5~10 브릭스로 농축하는 단계; Ii) extracting the herbal medicinal material consisting of mixed ginseng, angelica, baeksuoh, cheongoong, licorice and jujube, and concentrated to 5-10 brix;
ⅲ) 콩을 바실러스 아밀로리퀴페시언스 MGD02 균주로 발효하여 청국장을 제조하여 건조한 후, 건조된 청국장에 물을 첨가하여 끓여서 여과하고 20 ~ 40 브릭스로 농축하여 청국장 소스 스톡을 제조하는 단계; Iii) fermenting soybeans with Bacillus amyloliquefaciens MGD02 strain to prepare cheonggukjang, drying it, adding water to the dried cheonggukjang, boiling, filtering, and concentrating to 20 to 40 brix to prepare cheonggukjang sauce stock;
ⅳ) 간장, 식초, 설탕, 채소 육수의 혼합물에, 단계 ⅲ)에서 제조된 청국장 소스 스톡을 첨가하여 끓여 농축하고 여과하는 단계; 및Iv) adding the cheonggukjang sauce stock prepared in step iii) to a mixture of soy sauce, vinegar, sugar, and vegetable stock, boiling, concentrating and filtering; And
ⅴ) 단계 ⅰ) 및 ⅱ)에서 제조된 추출물들을, 단계 ⅳ)에서 제조된 여과액에 첨가하는 단계. V) adding the extracts prepared in steps i) and ii) to the filtrate prepared in step iv).
단계 ⅰ) 옻나무 혼합분말 Step i) Mixed powder of lacquer 송이버섯균사체Pine mushroom mycelium 발효추출물 제조 Manufacture of fermented extract
옻나무, 현미 및 콩으로 구성되는 혼합분말을 송이버섯균사체로 발효한 후, 에탄올로 추출하여 5~10 브릭스로 농축한다. After fermenting the mixed powder consisting of poison ivy, brown rice and soybeans with pine mushroom mycelium, extract with ethanol and concentrate to 5-10 brix.
혼합분말, 송이버섯균사체, 발효, 추출 및 농축은 상기에서 정의된 바와 같다. The mixed powder, pine mushroom mycelium, fermentation, extraction and concentration are as defined above.
단계 ⅱ) 한방약재의 추출물 제조Step ii) Preparation of herbal medicinal extract
산양삼과 인삼의 혼합삼, 당귀, 백수오, 천궁, 감초와 대추로 구성되는 한방약재를 에탄올 추출하여 5~10 브릭스로 농축한다. Herbal medicinal herbs consisting of mixed ginseng, angelica, baeksuoh, cheonggung, licorice, and jujube are extracted with ethanol and concentrated to 5-10 brix.
한방약재, 추출 및 농축은 상기에서 정의된 바와 같다. Herbal medicine, extraction and concentration are as defined above.
상기에서 정의된 바와 같이, 필요에 따라서, 단계 i)과 단계 ⅱ)의 추출은 각각 또는 혼합하여 수행될 수 있다. As defined above, if necessary, the extraction of steps i) and ii) may be performed individually or in combination.
단계 ⅲ) 청국장 소스 Step iii) Cheonggukjang sauce 스톡stock 제조 Produce
콩을 바실러스 아밀로리퀴페시언스 MGD02 균주로 발효하여 청국장을 제조하여 건조한 후, 건조된 청국장에 물을 첨가하여 끓여서 여과하고 20~40 브릭스로 농축하여 청국장 소스 스톡을 제조한다. Soybeans are fermented with Bacillus amyloliquefacians MGD02 strain to prepare cheonggukjang, dried, and then added water to the dried cheonggukjang, boiled, filtered, and concentrated to 20-40 brix to prepare cheonggukjang sauce stock.
본 발명에서 콩은 백태, 서리태, 또는 쥐눈이콩을 사용할 수 있다. 콩에 2~3 부피배의 물을 첨가하여 6~24시간 불린 후, 물기를 제거하고 100~120℃에서 15~60분 증자하고 35~45℃로 냉각하여 사용하는 것이 바람직하나, 이에 제한되는 것은 아니다.Beans in the present invention may be used as white tae, seoritae, or rat eyes. After adding 2 to 3 times the volume of water to the beans and soaking for 6 to 24 hours, it is preferable to remove the water, increase the water at 100 to 120°C for 15 to 60 minutes, and cool it to 35 to 45°C. It is not.
본 발명에 따른 바실러스 아밀로리퀴페시언스 MGD02는 균주는 통상의 방법에 따라 종배양하여 사용한다. 트리틱 소이 브로스 (TSB; Trytic Soy Broth) 액체배지에서 12시간 정도 배양한 배양액으로서 종배양할 수 있으나, 이에 제한되지는 않는다. 접종량은 2.5~5.0 %(v/w)로 이루어지는 것이 바람직한데, 5.0 %(v/w) 초과이면 종균 배양시 경제적 비용이 과다 발생하며, 2.5 %(v/w) 미만이면 청국장 발효 속도가 지연되어 청국장 발효 및 품질에 영향을 미칠 수 있다.Bacillus amyloliquefacience MGD02 according to the present invention is used after being cultured according to a conventional method. Tritic soy broth (TSB; Trytic Soy Broth) As a culture medium cultured for about 12 hours in a liquid medium, it may be seeded, but is not limited thereto. The inoculation amount is preferably made of 2.5~5.0%(v/w).If it exceeds 5.0%(v/w), economic costs are excessive during seed culture, and if it is less than 2.5%(v/w), the fermentation rate of Cheonggukjang is delayed. It can affect the fermentation and quality of Cheonggukjang.
발효는 35~45℃에서 2~5일간 발효시키는 것이 바람직하다. Fermentation is preferably fermented for 2 to 5 days at 35 to 45 ℃.
건조는 50~60℃에서 2~3일간 수행되는 것이 바람직하나, 이에 제한되는 것은 아니다. 건조 청국장으로 제조함에 의해, 청국장의 지속적인 발효에 의해 품질변화를 방지할 수 있고, 과발효에 의한 악취 등의 발생을 방지하여 일정한 품질을 유지할 수 있다.Drying is preferably performed for 2 to 3 days at 50 to 60° C., but is not limited thereto. By manufacturing dried cheonggukjang, quality change can be prevented by continuous fermentation of cheonggukjang, and odors due to over-fermentation can be prevented, thereby maintaining a certain quality.
건조된 청국장에 물의 첨가량은 건조 청국장의 2~5 부피배로 첨가하는 것이 바람직하다.The amount of water added to the dried cheonggukjang is preferably 2 to 5 times the volume of the dried cheonggukjang.
농축은 통상의 방법으로 할 수 있는데, 일례로서 처음에 강한 불로 가열하여 끓어오르면 중불로 낮추어 일정시간 끓여 추출하고 채반에서 걸러 여과하고 청국장 추출액을 중간불로 다시 일정시간 끓여서 적절한 농도로 20~40 브릭스로 농축할 수 있다.Concentration can be done in the usual way.For example, if it boils at first by heating it over strong heat, lower it to medium heat, boil it for a certain period of time, extract it, filter it on a tray, and boil the extract of cheonggukjang again for a certain period of time over medium heat to obtain an appropriate concentration. Can be concentrated.
단계 ⅳ) 소스 베이스 제조Step iv) Sauce Base Preparation
간장, 설탕, 식초 및 채소 육수의 혼합물에, 단계 ⅲ)에서 제조된 청국장 소스 스톡을 첨가하여 끓여 농축하고 여과하여 소스 베이스를 제조한다. To a mixture of soy sauce, sugar, vinegar and vegetable stock, the cheonggukjang sauce stock prepared in step iii) is added to boiled, concentrated, and filtered to prepare a sauce base.
채소 육수는 물에 무, 파, 버섯, 다시마 등을 넣고 1시간 이상 끓여 우려낸 것을 사용한다.Vegetable stock uses radish, green onions, mushrooms, kelp, etc., and boiled for at least 1 hour.
상기 혼합물에서 간장, 설탕, 식초, 채소 육수는 2~1 : 2~1 : 1~0.5 : 2~1의 부피비로 혼합될 수 있다. In the mixture, soy sauce, sugar, vinegar, and vegetable stock may be mixed in a volume ratio of 2 to 1: 2 to 1: 1 to 0.5: 2 to 1.
농축 및 (고형물의) 여과는 통상적인 방식으로 수행할 수 있다. 일례로서 처음에 강한 불로 가열하여 끓어오르면 중불로 낮추어 다시 일정시간 끓여서 적절한 농도로 농축할 수 있고, 여과는 채반을 이용하여 수행할 수 있다.Concentration and filtration (of solids) can be carried out in a conventional manner. As an example, if it boils by first heating over strong heat, it can be lowered to medium heat and boiled again for a certain period of time to concentrate to an appropriate concentration, and filtration can be performed using a tray.
단계 ⅴ) 추출물 첨가Step v) Add extract
단계 ⅰ) 및 ⅱ)에서 제조된 추출물들을, 단계 ⅳ)에서 제조된 여과액에 첨가하여 데리야끼 소스를 완성한다. The extracts prepared in steps i) and ii) are added to the filtrate prepared in step iv) to complete teriyaki sauce.
옻나무 혼합분말 발효추출물과 한방약재 추출물, 이들의 첨가량은 상기에서 정의된 바와 같다.The fermented lacquer mixed powder extract and herbal medicinal herb extract, and the amount of these added are as defined above.
필요에 따라서, 단계 v) 후에, 데리야끼 소스를 살균, 냉각 및/또는 포장의 단계를 추가로 포함할 수 있다.If necessary, after step v), the teriyaki sauce may be sterilized, cooled and/or packaged further.
본 발명에 따른 데리야끼 소스는 항산화 활성, 당뇨 개선 및 비만 개선의 기능성이 증진된 식물성 소스이다 (도 4a ~ 도 6).Teriyaki source according to the present invention is a vegetable source with improved antioxidant activity, improved diabetes and improved obesity (FIGS. 4A to 6 ).
본 발명에 따른 데리야끼 소스는 옻나무 혼합분말 송이버섯균사체 발효 추출물과 한방약재의 추출물을 포함하여, 페놀산, 플라보놀 등의 생리활성성분 특히, 퀘르세틴, 에피갈로카테킨 및 클로로제닉산을 고함량으로 함유하게 강화된다. Teriyaki sauce according to the present invention includes lacquer mixed powder matsutake mycelium fermentation extract and extracts of herbal medicinal herbs, including physiologically active ingredients such as phenolic acid and flavonol, in particular quercetin, epigallocatechin, and chlorogenic acid in a high content. It is strengthened to contain.
본 발명의 데리야끼 소스에 포함된 옻나무 송이버섯균사체 혼합분말 발효 추출물은 우루시올이 함유되지 않아서 알레르기 등의 유발없이 옻나무 유래의 유효한 생리활성성분을 포함하며, 송이버섯균사체로 발효되어 천연 지향적이고 기호성이 우수한 장점을 갖는다.The fermented extract of mixed powder of lacquer matsutake mycelium contained in the teriyaki sauce of the present invention does not contain urushiol, so it contains an effective physiologically active ingredient derived from lacquer without causing allergies, etc., and fermented with matsutake mycelium, which is naturally oriented and has excellent palatability. Has an advantage.
본 발명에 따른 데리야끼 소스는 항산화 활성, 당뇨병 개선 및 비만 개선의 기능성도 향상되어 있다. Teriyaki sauce according to the present invention has improved antioxidant activity, improved diabetes and improved obesity.
본 발명에 따른 식물성 데리야끼 소스는 식물성이면서 생리활성성분이 강화되고 우수한 기능성을 가져서 현대의 건강 지향적 트렌드에 부합되어 육고기 소스를 대체할 수 있으며, 채식주의자들을 위한 콩고기 등과 잘 어울리고, 튀기거나 훈제한 닭고기 또는 오리고기, 어패류 요리 등과도 잘 어울리는 소스이다.The vegetable teriyaki sauce according to the present invention is vegetable and has enhanced physiologically active ingredients and has excellent functionality, so it can replace meat sauce in accordance with the modern health-oriented trend, and it goes well with beans for vegetarians, fried or smoked. It is a sauce that goes well with chicken or duck meat and seafood dishes.
도 1은 옻나무 혼합분말 송이버섯균사체 발효물의 발효 전·후의 HPLC 크로마토그램을 나타낸다 (붉은 점선 부위는 우루시올 추출 시간을 나타냄).
도 2은 본 발명에 따른 데리야끼 소스의 제조 공정도의 일례를 나타낸 것이다.
도 3은 본 발명에 따른 데리야끼 소스의 HPLC 크로마토그램을 나타낸다 (붉은 점선 부위는 우루시올 추출 시간을 나타냄).
도 4는 본 발명에 따른 데리야끼 소스의 항산화 활성을 나타낸 그래프이다. 도 4a는 DPPH 라디칼 소거활성, 도 4b는 ABTS 라디칼 소거활성, 도 4c는 하이드록실 라디칼 소거활성, 및 도 4d는 FRAP 환원력을 나타낸다.
도 5은 본 발명에 따른 데리야끼 소스의 알파-글루코시다아제 저해활성을 나타낸다.
도 6은 본 발명에 따른 데리야끼 소스의 췌장-리파아제 저해활성을 나타낸다.Fig. 1 shows HPLC chromatograms before and after fermentation of fermented matsutake mushroom mycelia of lacquer tree mixed powder (red dotted line indicates urushiol extraction time).
Figure 2 shows an example of a manufacturing process diagram of the teriyaki sauce according to the present invention.
3 shows the HPLC chromatogram of the teriyaki sauce according to the present invention (the red dotted area indicates the urushiol extraction time).
Figure 4 is a graph showing the antioxidant activity of teriyaki sauce according to the present invention. 4A shows DPPH radical scavenging activity, FIG. 4B shows ABTS radical scavenging activity, FIG. 4C shows hydroxyl radical scavenging activity, and FIG. 4D shows FRAP reducing power.
Figure 5 shows the alpha-glucosidase inhibitory activity of teriyaki source according to the present invention.
Figure 6 shows the pancreatic-lipase inhibitory activity of teriyaki sauce according to the present invention.
다음의 실시예들에 의해 본 발명이 더 상세히 설명된다. 이들 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의해 제한되어서는 안된다.The present invention is explained in more detail by the following examples. These examples are intended to illustrate the invention, and the scope of the invention should not be limited by them.
제조예Manufacturing example 1. 옻나무 혼합분말 1. Mixed powder of lacquer 송이버섯균사체Pine mushroom mycelium 발효 및 분석 Fermentation and analysis
본 발명의 옻나무 혼합분말 발효물을 제조하고, 발효 전·후 알레르기 유발물질인 우루시올을 분석하였다.The fermented product of the lacquer tree mixed powder of the present invention was prepared, and urushiol, which is an allergy-inducing substance, was analyzed before and after fermentation.
<옻나무 혼합분말 발효><Lacquer mixed powder fermentation>
옻나무는 함양군 마천면 일대에서 채취한 것을 함양군농업기술센터로부터 공급받아 사용하였고, 콩은 풍산나물콩 품종을 농촌진흥청 국립식량원 남부작물부로부터 재배된 것을 공급받았고, 현미는 시중에 판매되는 것을 구입하였다. The lacquer tree was collected from Macheon-myeon, Hamyang-gun and was supplied from the Hamyang-gun Agricultural Technology Center, and the bean was supplied from the South Crop Department of the National Food Service of the Rural Development Administration, and brown rice was purchased on the market. .
송이버섯 균사체는 경상대학교 임산가공실험실로부터 분양받아 10% 백미 액체배지에 접종하여 25℃에서 5일간 배양하여 종균을 준비하였다. The pine mushroom mycelium was pre-sold from the forest processing laboratory of Gyeongsang National University, inoculated in 10% white rice liquid medium, and cultured at 25°C for 5 days to prepare a seed.
옻나무를 절단하여 100℃에서 1시간 처리한 후 55℃에서 2∼3일간 건조시킨 후, 분쇄기로 초핑하여 분말화하였다. 또한 콩과 현미 역시 분쇄기로 분쇄하여 분말로 제조하여 준비하였다.The lacquer was cut, treated at 100°C for 1 hour, dried at 55°C for 2 to 3 days, and then chopped with a grinder to powder. In addition, beans and brown rice were also pulverized with a grinder to prepare a powder.
옻나무 분말 120g, 콩 분말 40g 및 현미 분말 40g을 잘 혼합한 후 정제수를 첨가하여 수분을 50% 정도로 조정한 후, 121℃에서 30분 살균 처리하여 냉각한 후, 상기에서 준비된 송이버섯균사체 종균을 5%(v/v)에 접종하여 25 ℃에서 12일간 발효를 시킨 후 55℃에서 2∼3일간 건조시키고 분쇄기로 분쇄하여 분말로 제조하였다.After mixing well, 120 g of sumac powder, 40 g of soybean powder, and 40 g of brown rice powder, added purified water to adjust the moisture to about 50%, sterilized at 121°C for 30 minutes to cool, and then the matsutake mycelium spores prepared above were 5 %(v/v) was inoculated, fermented at 25°C for 12 days, dried at 55°C for 2-3 days, and pulverized with a grinder to prepare a powder.
<시료 준비><Sample preparation>
우루시올 분석을 위한 시료는 식품공전 일반시험법의 식품 중 유해물질 '우루시올 확인시험'에 준하여 준비하였다. 구체적으로는, 상기에서 제조된 옻나무 혼합분말 발효물 분말과 비교를 위하여 발효전 옻나무 혼합분말을 각각 20 g을 취하여 95% 에탄올 100 ml를 첨가한 후 3시간 이상 교반 추출한 후, 이를 부흐너 깔때기로 흡인여과 후 에탄올로 잔사 및 용기를 세척하여 여액을 모아 40℃ 이하의 수욕 중에서 감압농축했다. 잔류물을 아세토니트릴 2 ml에 녹여 0.45 ㎛ 시린지 필터로 여과한 후 시료로 준비하였다.Samples for urushiol analysis were prepared in accordance with the'Urusiol Identification Test' of harmful substances in food in the General Test Methods of the Food Code. Specifically, for comparison with the fermented lacquer mixed powder prepared above, 20 g of each lacquer mixed powder before fermentation was added and 100 ml of 95% ethanol was added, followed by stirring and extracting for at least 3 hours, and then using a Buchner funnel. After suction filtration, the residue and the container were washed with ethanol, and the filtrate was collected and concentrated under reduced pressure in a water bath of 40°C or less. The residue was dissolved in 2 ml of acetonitrile, filtered through a 0.45 μm syringe filter, and prepared as a sample.
<우루시올 분석> <Urusiol analysis>
우루시올 분석은 식품공전 일반시험법의 식품 중 유해물질 '우루시올 확인시험'을 약간 변형하여 고압 액상 크로마토그램(HPLC, Agilent 1200 series, Agilent Co)로 분석하였다. 이동상 용매는 2.0% 글라시알 아세트산(수중) (용매 A)와 아세토니트릴 (용매 B)로 분석하였고, 이동상 조건은 용매 B 기준으로 각각 5, 20, 27, 29 및 30분 동안 10%, 95%, 95%, 10% 및 10%로 유지시켰다. 시료는 20㎕를 주입하였으며 이동상 속도는 60℃에서 1ml/min으로 유지하였고 diode array UV detector (Agilent 1200 series, Agilent Co.)의 흡광도 276 nm에서 정량하여 표 1에 나타내고, HPLC 크로마토그램을 도 1에 나타냈다. Urushiol analysis was performed with a high-pressure liquid chromatogram (HPLC,
nd: 검출되지 않음All experiments were repeated five times and expressed as an average value.
nd: not detected
표 1 및 도 1에 나타낸 바와 같이, 발효 전에는 알레르기 유발물질인 우루시올이 1.52 mg/100 g 검출되었으나, 발효 후에는 전혀 검출되지 않아서 발효에 의해 알레르기 유발물질이 제거됨(무독화됨)을 확인할 수 있다.As shown in Table 1 and FIG. 1, 1.52 mg/100 g of urushiol, which is an allergen, was detected before fermentation, but it was not detected at all after fermentation, so that the allergen was removed (detoxified) by fermentation.
제조예Manufacturing example 2. 옻나무 혼합분말 2. Mixed powder of lacquer 송이버섯균사체Pine mushroom mycelium 발효물과Fermented products 한방약재의 추출물 제조 Manufacture of extracts of herbal medicine
<한방약재 분말 제조><Manufacture of herbal medicine powder>
산양삼은 함양군 서하면 일대에서 재배된 3년 이상을 구입하여 흐르는 물에 3회 세척한 후 55℃에선 2∼3일간 건조하여 준비하였고 인삼, 당귀, 백수오, 천궁, 감초 및 대추는 건조된 것을 산청군 금서면 소재 ㈜자연애제약에서 구입하였다.Sanyangsam was prepared by purchasing more than 3 years grown in Seo-myeon, Hamyang-gun, washing 3 times in running water and drying for 2-3 days at 55℃. Ginseng, angelica, baeksuoh, cinnamon, licorice and jujube were dried. It was purchased from Jayeonae Pharmaceutical Co., Ltd. located in Geumseo-myeon, Sancheong-gun.
산양삼, 인삼, 당귀, 백수오, 천궁, 감초 및 대추를 각각 분쇄기로 분쇄하여 분말로 제조하였고, 혼합삼 분말은 산양삼 분말과 인삼 분말을 1 : 9 (w/w)로 혼합하여 준비하였다. Wild ginseng, ginseng, angelica, baeksuoh, cheongoong, licorice, and jujube were pulverized into powders, respectively, and mixed ginseng powder was prepared by mixing wild ginseng powder and ginseng powder in a ratio of 1: 9 (w/w).
혼합삼 분말 20 g, 당귀 분말 20 g, 백수오 분말 20 g, 천궁 분말 20 g, 감초 분말 20 g 및 대추 분말 20 g을 잘 혼합한 후, 상기 제조예 1에서 제조된 옻나무 혼합분말 송이버섯균사체 발효물 분말 80 g을 혼합한 혼합분말에 10 g에 50% 에탄올 200 ml 첨가하여 최종 20배 희석한 후, 70℃에서 5시간 동안 600rpm 속도를 유지하여 추출하였다. 동일한 조건으로 2회 반복 추출하여 모은 후 여과지(No. 2, Whatman, Tokyo Roshi Kaisha, Ltd., Tokyo, Japan)로 여과한 후 가용성 고형분이 10 브릭스(brix)가 되게 감압농축기를 이용하여 농축하여 옻나무 혼합분말 송이버섯균사체 발효물과 한방약재의 복합 추출물을 제조하였다.After mixing well mixed ginseng powder 20 g, angelica powder 20 g, baekshou powder 20 g, cheonggung powder 20 g, licorice powder 20 g, and jujube powder 20 g, the lacquer tree mixed powder prepared in Preparation Example 1 matsutake mycelium To the mixed powder obtained by mixing 80 g of the fermented product powder, 200 ml of 50% ethanol was added to 10 g, diluted 20 times, and extracted by maintaining a speed of 600 rpm for 5 hours at 70°C. Extracted twice under the same conditions, collected, filtered with filter paper (No. 2, Whatman, Tokyo Roshi Kaisha, Ltd., Tokyo, Japan), and concentrated using a vacuum concentrator so that the soluble solid content becomes 10 brix. A complex extract of the fermented matsutake mushroom mycelium of lacquer tree mixed powder and herbal medicine was prepared.
제조예Manufacturing example 3. 청국장 소스 3. Cheonggukjang Sauce 스톡stock 제조 Produce
콩 1 kg을 약 2배의 물에서 약 12시간 동안 침지하고 나서 약 2시간 물을 빼고 120℃에서 30분간 증자한 후, 약 40℃로 냉각하여 증자된 콩을 발효 틀에 넣은 후, TSB 액체배지에서 12시간 정도 종배양한 바실러스 아밀로리퀴페시언스 MGD02 배양액 2.5 %(55 ml)를 접종하고, 37℃에서 72시간 동안 발효시켜 청국장을 제조하였고, 이를 50 ~ 60℃에서 2일간 건조하여 건조 청국장을 제조하였다. After soaking 1 kg of beans in about twice the amount of water for about 12 hours, drain the water for about 2 hours, cook for 30 minutes at 120℃, cool to about 40℃, and put the steamed beans in the fermentation mold, and then liquid TSB Inoculated with 2.5% (55 ml) of Bacillus amyloliquefacience MGD02 culture medium cultured for about 12 hours in a medium, and fermented at 37°C for 72 hours to prepare Cheonggukjang, which was dried at 50 to 60°C for 2 days and dried. Cheonggukjang was prepared.
건조 청국장 1 kg에 식수 4 L 첨가하고 처음에 강한 불로 가열하여 끓어오르면 중불로 낮추어 1시간 끓여 추출하고 채반에서 걸러 청국장 추출액 얻어 두고, 걸러낸 청국장 콩에 다시 식수 2 L 가하고 30분간 끓여 위에서와 같이 청국장 추출 과정을 2회 반복하여 청국장 추출액 전체를 모아 4 L가 되도록 한 후 중간불로 끓여 약 30 브릭스로 농축하여 청국장 소스 스톡를 제조하였다.Add 4 L of drinking water to 1 kg of dried cheonggukjang, first heat it over strong heat, and when it boils, lower it to medium heat and boil for 1 hour to extract. Filter it on a tray to get the cheonggukjang extract.Add 2L of drinking water to the filtered cheonggukjang bean and boil it for 30 minutes. The extracting process of cheonggukjang was repeated twice to collect the whole cheonggukjang extract so that it became 4L, then boiled over medium heat and concentrated to about 30 brix to prepare cheonggukjang sauce stock.
제조예Manufacturing example 4. 4. 데리야끼Teriyaki 소스 제조 Sauce manufacturing
제조예 2 및 3에서 제조된 옻나무 혼합분말 송이버섯균사체 발효물과 한방약재의 복합 추출물과 청국장 소스 스톡을 이용하여 데리야끼 소스를 제조하였다.Teriyaki sauce was prepared using the complex extract of the lacquer mixed powder prepared in Preparation Examples 2 and 3, the fermented matsutake mushroom mycelium and herbal medicinal herbs, and the cheonggukjang sauce stock.
채소 육수는 물 6,000 mL에 무 800 g, 파 150 g, 건표고버섯 30 g 및 건다시마 60 g을 넣고 100℃에서 1시간 끓여 냉각한 후 고형물을 걸러 준비하였다.Vegetable stock was prepared by adding 800 g of radish, 150 g of green onions, 30 g of dried shiitake mushrooms, and 60 g of dried seaweed to 6,000 mL of water, boiled at 100° C. for 1 hour, cooled, and filtered through the solids.
구체적으로는, 표 2에 나타낸 바와 같이, 간장 80ml, 황설탕 80ml, 채소 육수 120ml 및 식초 40ml의 혼합물에, 제조예 3에서의 청국장 소스 스톡 400 ml을 혼합하여 중간 불에서 200 ml이 될 때까지 농축한 후 체에 거르고 농축액 190 ml에, 제조예 2에서 제조한 추출물(가용성고형분 함량: 10 brix)을 각각 0 ml (대조예) 및 10 ml (약 5 부피%; 실시예) 첨가하여 데리야끼 소스를 제조하였다 (도 2). Specifically, as shown in Table 2, in a mixture of 80 ml of soy sauce, 80 ml of brown sugar, 120 ml of vegetable stock, and 40 ml of vinegar, 400 ml of the cheonggukjang sauce stock in Preparation Example 3 was mixed to reach 200 ml over medium heat. After concentration, sieve through a sieve, to 190 ml of the concentrate, 0 ml (control example) and 10 ml (about 5 vol%; Example) of the extract (soluble solid content: 10 brix) prepared in Preparation Example 2 were added, respectively, and teriyaki sauce Was prepared (Fig. 2).
시험예Test example 1. One. 데리야끼Teriyaki 소스의 알레르기 유발물질 함유 여부 분석 Analysis of whether the source contains allergens
제조예 4에 제조한 실시예의 데리야끼 소스에 대한 알레르기 유발물질인 우루시올 함유 여부 분석은 제조예 1에서와 동일한 방식으로 수행하였고, 그 결과의 HPLC 크로마토그램을 도 3에 나타냈다. The analysis of whether urushiol, which is an allergy-inducing substance, to the teriyaki sauce of the Example prepared in Preparation Example 4 was performed in the same manner as in Preparation Example 1, and the resulting HPLC chromatogram is shown in FIG. 3.
도 3에 도시된 바와 같이, 본 발명에 따른 데리야끼 소스에는 알레르기 유발물질인 우루시올이 검출되지 않았다.As shown in Figure 3, the teriyaki sauce according to the present invention did not detect the allergen urushiol.
시험예Test example 2. 2. 데리야끼Teriyaki 소스의 생리활성물질 분석 Analysis of bioactive substances in source
제조예 4에 제조한 실시예 및 대조예의 데리야끼 소스의 생리활성물질인 총 페놀릭스, 총 플라보노이드, 페놀산, 및 플라보놀을 분석하였다. Total phenolics, total flavonoids, phenolic acids, and flavonols, which are the physiologically active substances of the teriyaki sauce prepared in Preparation Example 4 and the teriyaki sauce were analyzed.
<시료 준비><Sample preparation>
제조예 4에 제조한 실시예 및 대조예의 데리야끼 소스를 각각 3차 증류수로 10 배 희석한 후 0.45 ㎛ 여과 필터로 여과한 액을 시료로 준비하였다. The teriyaki sauces of Examples and Control Examples prepared in Preparation Example 4 were diluted 10 times with tertiary distilled water, respectively, and then filtered through a 0.45 μm filtration filter to prepare a sample.
<총 페놀릭스와 총 플라보노이드 함량 분석><Analysis of total phenolics and total flavonoid content>
총 페놀릭스 함량은 Folin-Denis법을 약간 변형하여 측정하였다. 각각의 시료 0.5 ml를 시험관에 분주하고 25% Na2CO3 용액 0.5 ml를 첨가하여 3분간 정치시켰다. 그 후 2 N Folin-Ciocalteu phenol 용액 0.25 ml 첨가 및 혼합한 다음 30℃에서 1시간 동안 발색시켰다. 발색된 시료는 750 nm에서 분광광도계(Spectronic 2D)를 사용하여 흡광도를 측정하였고, 갈산를 이용하여 작성한 표준 검량곡선으로부터 값을 산출하였고, 그 결과를 표 3에 나타냈다. The total phenolics content was measured by slightly modifying the Folin-Denis method. 0.5 ml of each sample was dispensed into a test tube, 0.5 ml of a 25% Na 2 CO 3 solution was added and allowed to stand for 3 minutes. Then, 0.25 ml of a 2 N Folin-Ciocalteu phenol solution was added and mixed, followed by color development at 30° C. for 1 hour. The absorbance of the colored sample was measured using a spectrophotometer (Spectronic 2D) at 750 nm, and a value was calculated from a standard calibration curve prepared using gallic acid, and the results are shown in Table 3.
총 플라보노이드 함량은 Davis법으로 측정하였다. 각각의 시료 0.5 ml에 디에틸렌글리콜 1.0 ml 및 1 N-NaOH 0.01 ml를 가하여 37℃ 항온수조에서 1시간 방치시켰다. 그 후 분광광도계(Spectronic 2D)를 이용하여 420 nm에서 흡광도를 측정하였고, 루틴을 이용하여 작성한 표준 검량곡선으로부터 값을 산출하였고, 그 결과를 표 3에 나타냈다. Total flavonoid content was measured by the Davis method. To 0.5 ml of each sample, 1.0 ml of diethylene glycol and 0.01 ml of 1 N-NaOH were added and left in a constant temperature water bath at 37° C. for 1 hour. Thereafter, the absorbance was measured at 420 nm using a spectrophotometer (Spectronic 2D), and the value was calculated from a standard calibration curve prepared using a routine, and the results are shown in Table 3.
표 3에 나타낸 바와 같이, 본 발명에 따른 데리야끼 소스(실시예)는 총 페놀릭스 및 총 플라보노이드스의 함량이 각각 0.35 mg/ml (약 9.3% 증진) 및 0.19 mg/ml (약 12% 증진)으로, 대조예의 데리야끼 소스 (추출물이 첨가되지 않음)에 비하여 현저하게 증진되었다. As shown in Table 3, teriyaki sauce (Example) according to the present invention has a total phenolics and total flavonoid content of 0.35 mg/ml (approximately 9.3% enhancement) and 0.19 mg/ml (approximately 12% enhancement), respectively. As a result, it was significantly improved compared to the teriyaki sauce (extract was not added) of the control example.
<페놀산 및 플라보놀 분석><Phenolic acid and flavonol analysis>
페놀릭산과 플라보놀 물질 분석은 고압 액상 크로마토그램(High performance liquid chromatography, Agilent 1200 series, Agilent Co, Forest Hill, Vic, Australia)로 분석하였다. 이동상 용매는 2.0% 글라시알 아세트산(수중)(solution A)와 2.0% 아세토니트릴(글라시알 아세트산 중)(solution B)로 분석하였고, 이동상 조건은 용매 B 기준으로 각각 10, 15, 20, 25, 30, 35, 40, 45, 55 및 60분 동안 15%, 5%, 15%, 5%, 10%, 50%, 50%, 60%, 80% 및 90%로 유지시켰다. 각각의 시료는 20 ㎕를 주입하였으며 이동상 속도는 30℃에서 1ml/min으로 유지하였고 페놀산(phenolic acids) 물질은 diode array UV detector(Agilent 1200 series, Agilent Co.)의 흡광도 280nm에서 정량하였고, 플라보놀(flavonols) 물질은 흡광도 270nm에서 정량하여 그 결과를 각각 표 4 및 표 5에 나타냈다.The analysis of phenolic acid and flavonol substances was performed by high-performance liquid chromatography (
표 4에 나타낸 바와 같이, 본 발명에 따른 실시예의 데리야끼 소스는 페놀산 화합물의 함유량이 증가되었고, 특히 클로로제닉산(chlorgenic acid)은 453.14 ㎍/ml으로 고함량으로 함유하였다.As shown in Table 4, the teriyaki sauce of the examples according to the present invention had an increased content of a phenolic acid compound, and in particular, chlorgenic acid contained a high content of 453.14 µg/ml.
표 5에 나타낸 바와 같이, 본 발명에 따른 실시예의 데리야끼 소스는 플라보놀 화합물의 함량이 증가되었고, 특히 에피갈로카테킨(epigallocatechin)과 퀘르세틴(quercetin)은 각각 2483.87 ㎍/ml 및 1457.62 ㎍/ml으로 고함량으로 함유하였다.As shown in Table 5, the teriyaki sauce of the examples according to the present invention had an increased content of flavonol compounds, and in particular epigallocatechin and quercetin were 2483.87 μg/ml and 1457.62 μg/ml, respectively. It contained in a high content.
시험예Test example 3. 3. 데리야끼Teriyaki 소스의 항산화 활성 분석 Source's antioxidant activity assay
제조예 4에 제조한 실시예 및 대조예의 데리야끼 소스의 항산화 활성은 DPPH 라디칼 소거활성, ABTS 라디칼 소거활성, 하이드록실 라디칼 소거활성 및 FRAP 환원력을 측정하여 분석하였다.The antioxidant activity of the teriyaki source of Examples and Control Examples prepared in Preparation Example 4 was analyzed by measuring DPPH radical scavenging activity, ABTS radical scavenging activity, hydroxyl radical scavenging activity, and FRAP reducing power.
<시료 준비><Sample preparation>
제조예 4에 제조한 실시예 및 대조예의 데리야끼 소스를 각각 3차 증류수로 1배(원액), 5배, 10배, 50배 및 100배 희석한 후, 0.45 ㎛ 여과 필터로 여과하여 시료를 준비하였다. The teriyaki sauce of Example and Control Example prepared in Preparation Example 4 was diluted 1, 5, 10, 50, and 100 times with 3 distilled water, respectively, and then filtered through a 0.45 μm filtration filter to prepare a sample. I did.
<DPPH 라디칼 소거활성><DPPH radical scavenging activity>
DPPH 라디칼 소거활성은 상기에서 준비된 10배, 50배 및 100배 희석되어 여과된 각각의 시료 0.2 ml에, DPPH 용액(1.5-4 M) 0.8 ml를 첨가하여 균일하게 혼합한 30분간 방치한 후 525 nm에서 흡광도를 측정하여 수행하였다. DPPH 라디칼 소거활성의 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 다음 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 4a에 도시하였다. DPPH radical scavenging activity was obtained by adding 0.8 ml of DPPH solution (1.5 -4 M) to 0.2 ml of each sample diluted 10-fold, 50-fold and 100-fold and filtered, and allowed to stand for 30 minutes after uniformly mixing. It was carried out by measuring the absorbance at nm. The negative control of DPPH radical scavenging activity was performed in the same manner using distilled water instead of the sample, and the difference in absorbance was calculated as a percentage (%) by the following equation, and the result is shown in FIG. 4A.
라디칼 소거활성(%) = [1-(음성대조구 흡광도 ÷실험구 흡광도)] ×100Radical scavenging activity (%) = [1-(absorbance in negative control ÷ absorbance in experimental section)] ×100
도 4a에 도시된 바와 같이, 데리야끼 소스를 10배, 50배 그리고 100배로 희석하였을 때, 본 발명에 따른 실시예는 각각 80.45%, 46.1% 및 11.81%의 소거활성을 나타내어 대조예(75.97%, 41.9% 및 11%)에 비하여 증진된 소거 활성을 나타내었다.As shown in Figure 4a, when the teriyaki sauce was diluted 10 times, 50 times and 100 times, the examples according to the present invention exhibited scavenging activities of 80.45%, 46.1% and 11.81%, respectively, and thus the control examples (75.97%, and 100 times). 41.9% and 11%) showed enhanced scavenging activity.
<ABTS 라디칼 소거활성> <ABTS radical scavenging activity>
ABTS 라디칼 소거활성은 7mM ABTS 시약 5 ml과 140mM K2S2O8 (FW 270.3, Sigma 9392) 5 ml을 섞어 어두운 곳에 14~16시간 방치시켜 양이온 라디칼을 생성시킨 후, 이를 메탄올로 섞어 732nm에서 대조구의 흡광도 값이 0.7±0.02가 되도록 조절한 ABTS 용액을 사용하였다. ABTS radical scavenging activity was obtained by mixing 5 ml of 7mM ABTS reagent and 5 ml of 140mM K 2 S 2 O 8 (FW 270.3, Sigma 9392) and leaving it in a dark place for 14 to 16 hours to generate cation radicals, which were then mixed with methanol and mixed at 732 nm. The ABTS solution adjusted so that the absorbance value of the control was 0.7±0.02 was used.
상기에서 준비된 10배, 50배 및 100배 희석되어 여과된 각각의 시료 0.1 ml과 ABTS 용액 0.9 ml를 혼합하여 3분간 반응시키고 732nm에서 흡광도를 측정하였다. ABTS 라디칼 소거활성 역시 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 상기 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 4b에 도시하였다. 0.1 ml of each sample diluted 10 times, 50 times and 100 times prepared above and filtered and 0.9 ml of ABTS solution were mixed, reacted for 3 minutes, and absorbance was measured at 732 nm. The ABTS radical scavenging activity was also negative control using distilled water instead of the sample, and the difference in absorbance was calculated as a percentage (%) by the above equation, and the result is shown in FIG. 4B.
도 4b에 도시된 바와 같이, 본 발명에 따른 실시예의 데리야끼 소스가 대조예에 비하여 모두 증진된 소거 활성을 나타내었다. 데리야끼 소스를 10배, 50배 그리고 100배로 희석하였을 때, 본 발명에 따른 실시예는 각각 99.76%, 98.87% 및 44.53%의 소거활성을 나타내어 대조예(99.53%, 95.99% 및 41.33%)에 비하여 증진된 소거 활성을 나타내었다.As shown in Figure 4b, the teriyaki sauce of the embodiment according to the present invention all showed enhanced scavenging activity compared to the control example. When teriyaki sauce was diluted 10-fold, 50-fold, and 100-fold, the examples according to the present invention exhibited 99.76%, 98.87% and 44.53% of scavenging activity, respectively, compared to the control examples (99.53%, 95.99% and 41.33%). Showed enhanced scavenging activity.
<하이드록실 라디칼 소거활성><Hydroxy radical scavenging activity>
하이드록실 라디칼 소거활성은 10mM FeSO4 .7H20-EDTA 0.2 ml, 10mM 2-데옥시리보스 0.2 ml, 10mM H2O2 0.2 ml, 상기에서 준비된 10배, 50배 및 100배 희석되어 여과된 각각의 시료 1.4 ml를 혼합한 후 37℃에서 4시간 동안 반응시켜 혼합액을 만든 후, 이 혼합액에 1% 티오바르비탈산(in D.W)와 2.8% 트리클로로아세트산(in D.W)를 각각 1 ml를 가하여 100℃에서 20분간 발색시켜 냉각시킨 후 520nm에서 흡광도를 측정하였다. 음성 대조구로는 시료 대신에 PBS(1L 기준 NaCl 8.76g, NaH2PO4 0.11g, Na2HPO4 0.596g)을 사용하였다. 하이드록실 라디칼 소거활성은 시료 용액의 첨가구와 무첨가구 사이의 흡광도의 차이를 상기 식에 의해 % 값을 산출하였고, 그 결과를 도 4c에 나타냈다.The hydroxyl radical scavenging activity is 10mM FeSO 4 . 7H 2 0-EDTA 0.2 ml, 10 mM 2-deoxyribose 0.2 ml, 10 mM H 2 O 2 0.2 ml, and 1.4 ml of each sample diluted 10 times, 50 times and 100 times prepared above and filtered. After reacting at °C for 4 hours to prepare a mixture, 1 ml of 1% thiobarbital acid (in DW) and 2.8% trichloroacetic acid (in DW) were added to the mixture, followed by color development at 100 °C for 20 minutes and cooling. Absorbance was measured at 520 nm. As a negative control, PBS (1L NaCl 8.76g, NaH 2 PO 4 0.11g, Na 2 HPO 4 0.596g) was used instead of the sample. As for the hydroxyl radical scavenging activity, the difference in absorbance between the addition and no addition of the sample solution was calculated by the above equation, and the results are shown in FIG. 4C.
도 4c에 도시된 바와 같이, 본 발명에 따른 실시예의 데리야끼 소스가 대조예에 비하여 모두 증진된 소거 활성을 나타내었다. 특히 데리야끼 소스를 50배로 희석하였을 때, 본 발명에 따른 실시예는 19.29%의 소거활성을 나타내어 대조예(13.13%)에 비하여 상당히 높은 소거 활성을 나타내었다.As shown in Figure 4c, the teriyaki sauce of the embodiment according to the present invention all showed enhanced scavenging activity compared to the control example. In particular, when the teriyaki sauce was diluted 50 times, the Example according to the present invention exhibited a scavenging activity of 19.29%, showing a significantly higher scavenging activity compared to the control example (13.13%).
<FRAP 환원력><FRAP reducing power>
FRAP 환원력은 Acetate buffer (30 mM, pH 3.6), TPTZ 시약(10 mM in 40 mM HCl), 및 FeCl3 용액(20 mM in DW)을 10:1:1 (v/v/v)의 비율로 혼합하여 FRAP 측정 시약을 조제한 후, 37℃ 항온기에서 15분 예비반응시킨 후, 상기에서 준비된 10배, 50배 및 100배 희석되어 여과된 각각의 시료 50 ㎕와 FRAP 시약 950 ㎕를 시험관에 분주하여 37℃에서 15분 반응시키고 분광광도계를 사용하여 593nm에서 흡광도를 측정하였다. 음성대조구 실험은 시료 대신에 추출용매를 사용하였고, 그 결과를 도 4d에 나타내었다.FRAP reducing power is 10:1:1 (v/v/v) in Acetate buffer (30 mM, pH 3.6), TPTZ reagent (10 mM in 40 mM HCl), and FeCl 3 solution (20 mM in DW). After mixing to prepare a FRAP measuring reagent, pre-reacting for 15 minutes in a 37°C incubator, 50 µl of each sample diluted 10 times, 50 times and 100 times and filtered and 950 µl of FRAP reagent prepared above were dispensed into a test tube. The reaction was performed at 37° C. for 15 minutes, and absorbance was measured at 593 nm using a spectrophotometer. In the negative control experiment, an extraction solvent was used instead of the sample, and the results are shown in FIG. 4D.
도 4d에 도시된 바와 같이, 본 발명에 따른 실시예의 데리야끼 소스가 대조예에 비하여 모두 증진된 환원력을 나타내었다. 특히 데리야끼 소스를 10배로 희석하였을 때, 본 발명에 따른 실시예는 1.535의 환원력을 나타내어 대조예(1.384)에 비하여 상당히 높은 환원력을 나타냈다. As shown in Figure 4d, the teriyaki sauce of the embodiment according to the present invention all showed enhanced reducing power compared to the control example. In particular, when the teriyaki sauce was diluted 10 times, the example according to the present invention exhibited a reducing power of 1.535, which was considerably higher than that of the control example (1.384).
시험예Test example 4. 4. 데리야끼Teriyaki 소스의 Source of 항당뇨Antidiabetic 및 And 항비만Anti-obesity 활성 분석 Activity assay
제조예 4에 제조한 실시예 및 대조예의 데리야끼 소스의 항당뇨 활성 및 항비만 활성은 항당뇨 효과의 지표인 알파-글루코시다아제 저해활성과 항비만 효과의 지표인 췌장-리파아제 저해활성 측정을 통해 분석하였다.The anti-diabetic activity and anti-obesity activity of the teriyaki sauce of Examples and Control Examples prepared in Preparation Example 4 were determined through measurement of alpha-glucosidase inhibitory activity, an indicator of anti-diabetic effect, and pancreatic-lipase inhibitory activity, an indicator of anti-obesity effect. Analyzed.
<항당뇨 활성><Antidiabetic activity>
알파-글루코시아다제(α-Glucosidase) 저해활성은 상기에서 준비된 1배, 5배 및 10배 희석되어 여과된 각각의 시료 50 ㎕, 알파-글루코시아다제(0.5 U/ml) 효소용액 50 ㎕, 200 mM 인산나트륨 완충용액(pH 6.8) 50 ㎕를 혼합하여 37℃에서 10분간 예비반응시켰다. 이후 인산나트륨 완충용액(pH 6.8)에 녹인 p-NPG(5 mM) 100 ㎕를 첨가하여 다시 37℃에서 10분 반응시켰다. 이 반응액에 Na2CO3 (100 mM) 0.75 ml를 가해 최종 반응을 정지시킨 후 420nm에서 분광광도계를 이용하여 흡광도를 측정하고 음성대조구로 증류수를 사용하여 상기 식에 의해 백분율(%)을 계산하였고 그 결과를 도 5에 나타내었다.Alpha-glucosidase inhibitory activity is 50 µl of each sample diluted 1, 5- and 10-fold prepared above and filtered, 50 µl of alpha-glucosidase (0.5 U/ml) enzyme solution, 50 µl of 200 mM sodium phosphate buffer solution (pH 6.8) was mixed and pre-reacted at 37°C for 10 minutes. Thereafter, 100 µl of p- NPG (5 mM) dissolved in a sodium phosphate buffer solution (pH 6.8) was added and reacted again at 37° C. for 10 minutes. Na 2 CO 3 in this reaction solution After adding 0.75 ml of (100 mM) to stop the final reaction, the absorbance was measured using a spectrophotometer at 420 nm, and the percentage (%) was calculated by the above equation using distilled water as a negative control, and the results are shown in FIG. Done.
도 5에 도시된 바와 같이, 본 발명에 따른 데리야끼 소스(실시예)는 대조예에 비하여 증진된 알파-글루코시아다제 저해활성을 나타냈고, 특히 5배 희석하였을 때, 본 발명에 따른 실시예는 20.5%로 대조예(17.54%)에 비하여 상당히 증진된 저해활성을 나타냈다. As shown in Figure 5, the teriyaki sauce (Example) according to the present invention exhibited an enhanced alpha-glucosiadase inhibitory activity compared to the control example, particularly when diluted 5 times, the Example according to the present invention It showed significantly enhanced inhibitory activity compared to the control example (17.54%) at 20.5%.
<항비만 활성><Anti-obesity activity>
췌장 리파아제 저해활성은 상기에서 준비된 1배, 5배 및 10배 희석되어 여과된 각각의 시료 50 ㎕, 췌장 리파아제 효소용액(1.0 U/mL) 50 ㎕ 및 pH 6.8로 조정된 인산나트륨 완충액(100 mM) 50 ㎕를 혼합하여 37℃의 수욕상에서 10분간 예비반응시키고 인산나트륨 완충액에 녹인 p-NPB (5 mM) 100 ㎕를 첨가 후 다시 10분간 반응시킨 후 탄산나트륨(100 mM) 0.75 ml를 가해 효소반응을 종결시켜 420nm에서 흡광도를 측정하였다. 음성대조구는 시료 대신에 증류수를 취하였으며 시료용액의 첨가구와 무첨가구 사이의 흡광도 차이를 상기 식에 의해 백분율(%)로 산출하였고, 그 결과를 도 6에 나타내었다.Pancreatic lipase inhibitory activity is 50 µl of each sample diluted 1, 5- and 10-fold and filtered, 50 µl of pancreatic lipase enzyme solution (1.0 U/mL) and sodium phosphate buffer (100 mM) adjusted to pH 6.8. ) 50 µl was mixed and pre-reacted in a water bath at 37°C for 10 minutes, 100 µl of p- NPB (5 mM) dissolved in sodium phosphate buffer was added, reacted for 10 minutes, and then 0.75 ml of sodium carbonate (100 mM) was added to the enzyme reaction. Was terminated and the absorbance was measured at 420 nm. As the negative control, distilled water was taken instead of the sample, and the difference in absorbance between the addition and the non-addition of the sample solution was calculated as a percentage (%) by the above equation, and the results are shown in FIG.
도 6에 도시된 바와 같이, 본 발명에 따른 데리야끼 소스(실시예)는 대조예에 비하여 현저히 증진된 췌장 리파아제 저해활성을 나타냈고, 실시예는 원액(1배) 희석일때는 38.66%, 5배 희석시에는 23.21%, 10배 희석시에는 13%의 저해활성을 나타내어, 대조예(각각 29.14%, 20.24%, 8.14%)에 비하여 현저히 높은 저해활성을 보였다.As shown in Fig. 6, the teriyaki sauce (Example) according to the present invention exhibited significantly enhanced pancreatic lipase inhibitory activity compared to the control example, and in Example, 38.66%, 5 times when diluted with a stock solution (1 times) At the time of dilution, the inhibitory activity was 23.21%, and at the time of 10-fold dilution, 13% was shown, and significantly higher inhibitory activity was shown compared to the control examples (29.14%, 20.24%, 8.14%, respectively).
시험예Test example 5. 5. 데리야끼Teriyaki 소스의 이화학적 특성 Physicochemical properties of the sauce
제조예 4에 제조한 실시예 및 대조예의 데리야끼 소스의 이화학적 특성은 의 pH, 산도, 가용성 고형물, 환원당 및 수용성 단백질 함량을 측정하여 분석하였다. The physicochemical properties of the teriyaki sauce of Examples and Control Examples prepared in Preparation Example 4 were analyzed by measuring the pH, acidity, soluble solids, reducing sugar and water-soluble protein contents of.
pH는 pH 미터기(MP 200, UK)로 측정하였고, 산도는 0.1 N NaOH를 사용하여 pH 8.2±0.2까지 중화시켰을 시 소요되는 소비량을 젖산양으로 환산하여 %로 표시하였고, 가용성 고형물 함량은 굴절 당도계를 사용하여 측정하였다. 환원당은 DNS법에 따라 각각의 분석시료 0.1 ml에 DNS 시약 1 ml를 첨가하여 100℃에서 20분 발색시킨 후 급속히 냉각하고 분광광도계를 사용하여 570nm에서 흡광도를 측정하여 검량선과 비교하였다.The pH was measured with a pH meter (
수용성 단백질 함량은 biuret법을 통하여 실시하였다. 즉, CuSO4·5H2O (황산구리 5수화물) 1.5 g에 KNaC4H4O6·4H2O (주석산칼륨 나트륨) 6.0 g을 500 ml의 증류수에 녹이고 10% NaOH 300 ml를 가한 후 최종 부피가 1,000 ml가 되게끔 정용하여 biuret 시약을 제조하였다. 각각의 시료 1 g을 시험관에 취하고 여기에 biuret 시약 4 ml를 첨가 및 혼합하여 37℃에서 20분간 반응시켰다. 이때 음성대조구는 증류수를 취하여 진행하였으며 20분 반응 후 3분간 원심분리 하여 상등액을 540nm에서 흡광도를 측정하고 단백질 표준곡선(bovine serum albumin)에 의해 산출된 계산식에 따라 수용성 단백질을 정량하여 표 6에 나타내었다.The water-soluble protein content was carried out through the biuret method. That is, after dissolving 6.0 g of KNaC 4 H 4 O 6 4H 2 O (sodium potassium tartrate) to 1.5 g of CuSO 4 5H 2 O (copper sulfate pentahydrate) in 500 ml of distilled water and adding 300 ml of 10% NaOH, the final volume Biuret reagent was prepared by diagnosing to be 1,000 ml. 1 g of each sample was taken into a test tube, and 4 ml of a biuret reagent was added and mixed thereto, followed by reaction at 37°C for 20 minutes. At this time, the negative control was carried out by taking distilled water, and after 20 minutes reaction, centrifugation for 3 minutes, the supernatant was measured absorbance at 540 nm, and the water-soluble protein was quantified according to the calculation formula calculated by the protein standard curve (bovine serum albumin), and is shown in Table 6. Done.
표 6에 나타낸 바와 같이, 실시예의 데리야끼 소스가 대조예에 비하여 산도, 가용성 고형분, 환원당 함량, 및 수용성 단백질 함량이 높았다.As shown in Table 6, the teriyaki sauce of Examples had higher acidity, soluble solids, reducing sugar content, and water-soluble protein content compared to the control example.
Claims (6)
옻나무 분말 60∼80%(w/w), 현미 분말 10∼20%(w/w) 및 콩 분말 10~20%(w/w)로 구성되는 혼합분말을 송이버섯균사체로 발효하여 에탄올 추출하여 5~10 브릭스로 농축하여 제조된 송이버섯균사체 발효 추출물 3~6 부피%;
산양삼과 인삼의 혼합삼 15~25%(w/w), 당귀 15~25%(w/w), 백수오15~25%(w/w), 천궁 15~25%(w/w), 감초 15~25%(w/w) 및 대추 15~25%(w/w)로 구성되는 한방약재를 에탄올 추출하여 5~10 브릭스로 농축하여 제조된 한방약재의 추출물 3~6 부피%; 및
콩을 수탁번호 KACC92158P로 기탁된 바실러스 아밀로리퀴페시언스 MGD02 균주로 발효하여 청국장을 제조하여 건조한 후, 건조된 청국장에 물을 첨가하여 끓여서 여과하고 20~40 브릭스로 농축하여 제조된 청국장 소스 스톡 50~60 부피%를 포함하고,
상기 퀘르세틴, 에피갈로카테킨 및 클로로제닉산은 각각 1,450 ㎍/ml 이상, 2,480 ㎍/ml 이상 및 450 ㎍/ml 이상으로 강화된 것을 특징으로 하는 데리야끼 소스.
Teriyaki sauce with enhanced physiologically active components of quercetin, epigallocatechin and chlorogenic acid. The teriyaki sauce
Mixed powder consisting of sumac powder 60-80% (w/w), brown rice powder 10-20% (w/w) and soybean powder 10-20% (w/w) is fermented with pine mushroom mycelium and extracted with ethanol. Pine mushroom mycelium prepared by concentrating with 5-10 brix 3-6% by volume of fermented extract;
Mixed ginseng of wild and ginseng 15~25%(w/w), Angelica 15~25%(w/w), Baeksuo 15~25%(w/w), Cheongung 15~25%(w/w), 3-6% by volume of extracts of herbal medicinal herbs prepared by ethanol extraction of oriental medicinal herbs consisting of 15-25% (w/w) licorice and 15-25% (w/w) jujubes and concentrating to 5-10 brix; And
Cheonggukjang sauce stock 50 prepared by fermenting soybeans with Bacillus amyloliquefaciens MGD02 strain deposited under the accession number KACC92158P to prepare and dry Cheonggukjang, add water to the dried Cheonggukjang, boil, filter, and concentrate to 20-40 brix. Contains ~60% by volume,
Teriyaki sauce, characterized in that the quercetin, epigallocatechin, and chlorogenic acid are fortified to 1,450 µg/ml or more, 2,480 µg/ml or more, and 450 µg/ml or more, respectively.
The mixed powder of claim 1, wherein the fermentation extract is composed of lacquer tree powder 60-80% (w/w), brown rice powder 10-20% (w/w), and soybean powder 10-20% (w/w). After adding water to 50~60% moisture, swelling for 1~2 hours, sterilizing at 100~120℃ for 30~60 hours, inoculating matsutake mycelium at 3~6% (v/w) to ferment semi-solid Teriyaki sauce enriched with physiologically active components of quercetin, epigallocatechin and chlorogenic acid, characterized in that it is prepared by extracting with 40-70% ethanol and filtering to adjust the soluble solid content to 5-10 brix.
ⅰ) 옻나무, 현미 및 콩으로 구성되는 혼합분말을 송이버섯균사체로 발효하여 에탄올 추출하여 5~10 브릭스로 농축하는 단계;
ⅱ) 산양삼과 인삼의 혼합삼, 당귀, 백수오, 천궁, 감초와 대추로 구성되는 한방약재를 에탄올 추출하여 5~10 브릭스로 농축하는 단계;
ⅲ) 콩을 수탁번호 KACC92158P로 기탁된 바실러스 아밀로리퀴페시언스 MGD02 균주로 발효하여 청국장을 제조하여 건조한 후, 건조된 청국장에 물을 첨가하여 끓여서 여과하고 20~40 브릭스로 농축하여 청국장 소스 스톡을 제조하는 단계;
ⅳ) 간장, 식초, 설탕 및 채소 육수의 혼합물에, 단계 ⅲ)에서 제조된 청국장 소스 스톡을 첨가하여 끓여 농축하고 여과하는 단계; 및
ⅴ) 단계 ⅰ) 및 ⅱ)에서 제조된 추출물들을, 단계 ⅳ)에서 제조된 여과액에 첨가하는 단계를 포함하고,
상기 퀘르세틴, 에피갈로카테킨 및 클로로제닉산은 각각 1,450 ㎍/ml 이상, 2,480 ㎍/ml 이상 및 450 ㎍/ml 이상으로 강화되는 것을 특징으로 하는 제조방법.A method for preparing teriyaki sauce enriched with physiologically active components of quercetin, epigallocatechin and chlorogenic acid according to claim 1, wherein the method comprises:
I) fermenting the mixed powder consisting of lacquer, brown rice, and soybeans with pine mushroom mycelium, extracting ethanol, and concentrating to 5-10 brix;
Ii) extracting the herbal medicinal material consisting of mixed ginseng, angelica, baeksuoh, cheongoong, licorice and jujube, and concentrated to 5-10 brix;
Iii) After fermenting soybeans with Bacillus amyloliquefaciens MGD02 strain deposited under the accession number KACC92158P to prepare cheonggukjang, dry it, add water to the dried cheonggukjang, boil it, filter it, and concentrate it to 20~40 brix to make cheonggukjang sauce stock Manufacturing steps;
Iv) adding the cheonggukjang sauce stock prepared in step iii) to the mixture of soy sauce, vinegar, sugar and vegetable stock, boiling, concentrating and filtering; And
V) adding the extracts prepared in steps ii) and ii) to the filtrate prepared in step iv),
Wherein the quercetin, epigallocatechin, and chlorogenic acid are fortified to 1,450 μg/ml or more, 2,480 μg/ml or more, and 450 μg/ml or more, respectively.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190039279A KR102199387B1 (en) | 2019-04-03 | 2019-04-03 | Teriyaki Sauce having high biological active materials and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190039279A KR102199387B1 (en) | 2019-04-03 | 2019-04-03 | Teriyaki Sauce having high biological active materials and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200117321A KR20200117321A (en) | 2020-10-14 |
KR102199387B1 true KR102199387B1 (en) | 2021-01-06 |
Family
ID=72847588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190039279A KR102199387B1 (en) | 2019-04-03 | 2019-04-03 | Teriyaki Sauce having high biological active materials and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102199387B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101917534B1 (en) * | 2017-08-31 | 2018-11-09 | 경남과학기술대학교 산학협력단 | Vegetable Brown Sauce with enhanced taste and anti-oxydant property and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101277760B1 (en) * | 2010-11-15 | 2013-06-25 | 대한민국 | Process for production of urushiol free lacquer tree bark extract and its utilization |
KR101889596B1 (en) * | 2015-11-02 | 2018-08-20 | 경남과학기술대학교 산학협력단 | Composition of mixed grains fermented with Tricholoma matsutake mycelium having excellent flavor and enhanced functionality, and preparation method thereof and use thereof in food industry |
-
2019
- 2019-04-03 KR KR1020190039279A patent/KR102199387B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101917534B1 (en) * | 2017-08-31 | 2018-11-09 | 경남과학기술대학교 산학협력단 | Vegetable Brown Sauce with enhanced taste and anti-oxydant property and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20200117321A (en) | 2020-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102231913B1 (en) | Vegetable Brown Sauce having high biological active materials and preparation method thereof | |
KR102386296B1 (en) | Complex-fermented composition of Fabaton soybean leaves and Schisandra chinensis having enhanced anti-diabetic and anti-obesity effects and preparation method thereof | |
KR100512328B1 (en) | Method for manufacturing lacquer juice using fermentation with koji molds and lacquer juice produced using the same | |
KR101889596B1 (en) | Composition of mixed grains fermented with Tricholoma matsutake mycelium having excellent flavor and enhanced functionality, and preparation method thereof and use thereof in food industry | |
KR102387371B1 (en) | Fermented Stauntonia hexaphylla with improved antioxidant activity and uses thereof | |
KR101963978B1 (en) | Composition of fermented sprout ginseng having increased ginsenosides Rh2 and compound K, bioactive components, and preparation method thereof | |
KR101963046B1 (en) | Composition of processed ginseng having increased ginsenoside compound K, chlorgenic acid and quercetin, and preparation method thereof | |
KR101253658B1 (en) | Manufacturing method of treated puffing and fermentation red ginseng concentrate | |
KR101830048B1 (en) | Food composition for improvement obesity or improvement hyperlipidemic with the extract of Terminalia chebula fruit and Phyllanthus emblica | |
KR101917822B1 (en) | Production method of cirsimaritin fortified thistle concentrate using Lactobacillus plantarum KCCM 11322 strain | |
KR102137136B1 (en) | Composition comprising pumpkin hydrolysis extract, amorphophallus paeoniifolius hydrolysis extract, curcuma extract and cacao nibs extract | |
KR100872158B1 (en) | The manufacturing process of roasting and fermented red ginseng and mountain ginseng extracts | |
KR101416492B1 (en) | Fermented Tea Using Jujube Leaves and Green Tea Leaves and There of Manufacturing Method | |
KR20130019826A (en) | The manufacturing method of fermented citrus peel extract with anti-obesity nature and the product | |
KR102199387B1 (en) | Teriyaki Sauce having high biological active materials and preparation method thereof | |
KR101993441B1 (en) | manufacturing method of fermentation rice containing flavonoid | |
KR101508726B1 (en) | Preparation Method for Soy Sauce Comprising Astragalus membranaceus and Lentinula edodes | |
KR102464052B1 (en) | Composition of complex-fermented sprout ginseng having increased ginsenoside F2, Rg3, Rd2 and compound K, chlorogenic acid, coumaric acid, catechin and quercetin, and preparation method thereof | |
KR102249711B1 (en) | Composition for enhancing skin elasticity or improving skin wrinkels comprising enzyme treated extract of leguminous plants cultured root | |
KR20210093043A (en) | Food composition for antioxidant comprising extract of nypa fruticans wurmb and manufacturing method thereof | |
KR20200013327A (en) | Food composition for anti-oxidant and anti-inflammatory comprising extract of fermented soybean and preparation method thereof | |
KR102367647B1 (en) | Production method of egg having anti-oxidant ability and blood circulation ability using the feed composition for chicken including rhus verniciflua extract, and egg produced by the same method | |
KR102619236B1 (en) | The method of manufacturing barley doenjang using fermented rice-soybean lump and medicinal herbs | |
KR101668153B1 (en) | Law Sodium Soybean Paste and Soybean Paste Powder and Soybean Paste Pill Comprising Polyphenol and Manufacturing Method There of | |
KR102599866B1 (en) | Manufacturing Method of Chestnut inner Shell Tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |